Five of the pharmacy benefit manager industry's top executives head to Capitol Hill this week for a pair of back-to-back hearings on high drug prices.
Five of the pharmacy benefit manager industry's top executives head to Capitol Hill this week for a pair of back-to-back hearings on high drug prices.